Company Monitoring Page for Genentech

latest headlines for company on cafepharma

Roche Worker Sues For Whistleblowing & Firing
Pharmalot
Tue, 08/14/12 - 11:00 am
Tags:
Roche, Genentech, whistleblower lawsuits
FDA Approves Lucentis (Ranibizumab Injection) for Treatment of Diabetic Macular Edema (DME)
Pipeline Review
Sat, 08/11/12 - 12:57 pm
Tags:
Lucentis, Genentech, Roche, diabetic macular edema
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:12 pm
Tags:
Xenon, Virobay, Tolero Pharmaceuticals, Threshold Pharmaceuticals, Novartis, Merck KGaA, Merck, MannKind, licensing, Janssen, Isis Pharmaceuticals, Ironwood, Inhibrx Thrombogenics, GSK, Genmab, Genentech, Galapagos, Forma Therapeutics, Endocyte, Endo, Enanta, Celgene, Bristol-Myers Squibb, Boehringer Ingelheim, Bionomics, Biogen Idec, BioDelivery Sciences, AstraZeneca, Angiochem, AC Immune, Abbott Laboratories, LEO Pharma
PDL's Royalty Agreement with Genentech, and What This Means For Healthcare Stocks
Seeking Alpha
Tue, 06/19/12 - 12:10 pm
Tags:
breast cancer, PDL Biopharma, Genentech, Roche, Symmetry Medical, Rigel, Medivation, MRI Interventions, BioSante, Horizon Pharma, Pertuzumab
Study: 'Smart bomb' drug attacks breast cancer
Yahoo/AP
Sun, 06/3/12 - 11:13 am
Tags:
T-DM1, breast cancer, Genentech, Roche
ASCO spotlight: Antibody-drug conjugates arrive
Fierce Biotech
Fri, 06/1/12 - 12:28 pm
Tags:
ASCO, antibody-drug conjugate, Roche, Genentech, Immunogen, T-DM1, Adcetris, Seattle Genetics
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
Tags:
ASCO, Genentech, T-DM1, breast cancer, tivozanib, Aveo, kidney cancer, Onyx, Bayer, regorafenib, colorectal cancer, Adcetris, Seattle Genetics, JNJ, prostate cancer, Zytiga, cabozantinib, Exelixis, Enzalutamide, Medivation, Ponatinib, chronic myeloid leukemia, Ariad Pharmaceuticals
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
Tags:
BB1608, Boston Biomedical, Dainippon Sumitomo, cabozantinib, Exelixis, ONYX Pharmaceuticals, Carfilzomib, Medivation, Astellas, Enzalutamide, Ariad Pharmaceuticals, Ponatinib, Bayer, regorafenib, Oncovex, Amgen, Roche, Genentech, T-DM1, Immunogen, Aveo, tivozanib, Zaltrap, Sanofi, Regeneron
Synthon Pharmaceuticals Successfully Concluded Phase I Clinical Trial for Trastuzumab
Pipeline Review
Sun, 03/25/12 - 12:39 pm
Tags:
Synthon Pharmaceuticals, trastuzumab, Herceptin, breast cancer, gastric cancer, biosimilars, Genentech
Sanofi Loses Appeal in Roche Suit Over Rituxan, Avastin
Bloomberg
Fri, 03/23/12 - 11:30 am
Tags:
lawsuits, Sanofi, Roche, Rituxan, Avastin, Genentech, Biogen Idec
Roche Settles Claims Over Genentech’s Raptiva Psoriasis Drug, Lawyer Says
Bloomberg
Tue, 01/24/12 - 10:57 am
Tags:
Raptiva, settlements, Roche, Genentech, psoriasis
Regeneron settles with Genentech over eye drug
Yahoo/AP
Tue, 01/3/12 - 11:29 am
Tags:
Regeneron, Genentech, Eyelea
New Setback for Avastin as Breast Cancer Treatment
NY Times, NY
Thu, 12/8/11 - 11:39 am
Tags:
breast cancer, Avastin, Roche, Genentech
Big promise is seen in 2 new breast cancer drugs
Yahoo/AP
Wed, 12/7/11 - 10:13 pm
Tags:
breast cancer, Genentech, Pertuzumab, Afinitor, Novartis
Genmab says rivals appeal U.S. ruling in patent suit
Reuters
Tue, 12/6/11 - 11:33 am
Tags:
patents, Genmab, Biogen Idec, Genentech, GSK, Arzerra
F.D.A. Revokes Approval of Avastin as Breast Cancer Drug
NY Times, NY
Fri, 11/18/11 - 11:51 am
Tags:
FDA, Avastin, breast cancer, Roche, Genentech
VA Reinstates Avastin Usage For Eye Disease
Pharmalot
Thu, 11/10/11 - 01:13 pm
Tags:
Veterans Administration, Avastin, Lucentis, age-related macular degeneration, Genentech
Curis Earns $8 Million Milestone As NDA Accepted By FDA
Seeking Alpha
Thu, 11/10/11 - 01:08 pm
Tags:
Curis, milestone payments, FDA, basal cell carcinoma, Genentech, vismodegib
Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor
Seeking Alpha
Sun, 10/16/11 - 07:05 pm
Tags:
Micromet, Pfizer, blinatumomab, acute lymphoblastic leukemia, leukemia, Bmab, SAR3419, Sanofi, inotuzumab, Genentech, Seattle Genetics
Doctors Grow Wary of Avastin for Eye Treatment
NY Times, NY
Wed, 10/5/11 - 10:55 am
Tags:
Genentech, Avastin, Lucentis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.